In vitro susceptibility of 104 clinical isolates of Haemophilus influenzae to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin

Open Access
Publisher Website
Google Scholar
Abstract
A total of 104 strains of Haemophilus influenzae isolated from pediatric patients over a 1-year period were tested for susceptibility to moxalactam (LY127935), ampicillin, chloramphenicol, and ticarcillin. Of these strains, 30 produced beta-lactamase. LY127935 inhibited 99% of the strains at a concentration of 0.125 microgram/ml; the remaining strain was inhibited by this antibiotic at 0.25 microgram/ml. beta-Lactamase-producing strains were inhibited by ampicillin at greater than or equal to 2 microgram/ml. beta-Lactamase-negative strains were all inhibited by ampicillin at less than or equal to 1 microgram/ml, except for one nontypable strain which required 2 microgram of ampicillin per ml for inhibition. All strains were susceptible to chloramphenicol at less than or equal to 4 microgram/ml. beta-Lactamase-producing strains were less susceptible (geometric mean = 4.702 microgram/ml) to ticarcillin than were strains which did not produce beta-lactamase (geometric mean = 0.331 microgram/ml). LY127935 susceptibility was not influenced by increasing inoculum size, as ws ampicillin susceptibility. Combinations of LY127935 and chloramphenicol or ampicillin were not antagonistic in vitro.

This publication has 13 references indexed in Scilit: